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Postoperative hemorrhage remains a significant cause ofmortality and morbidity after repair of acute aortic dis-section. Accordingly, there has been great interest in thedevelopment and application of biologic hemostatic tis-
sue sealants for use during this and other aortic surgical proce-
dures.1 Among these agents, BioGlue (Cryolife, Inc, Kennesaw,
Ga) appears remarkably effective and has rapidly gained wide
acceptance.1,2 However, because it is composed of 45% (wt/vol)
purified bovine albumin and 10% (wt/vol) glutaraldehyde in a 4:1
ratio, we have been concerned that it might not be completely
innocuous. We have recently encountered a case of late anasto-
motic pseudoaneurysm potentially related to the use of BioGlue.
Clinical Summary
During cardiologic evaluation of recurrent atrial flutter, a 76-year-
old man was found to have a pseudoaneurysm of the ascending
aorta. Two years previously, he had an acute type A dissection, for
which he underwent graft replacement of the ascending aorta and
hemiarch, as well as bioprosthetic aortic valve replacement, at
another institution. In addition, he had a stable 3.1-cm abdominal
aortic aneurysm, chronic obstructive pulmonary disease, history of
seizure disorder, and recurrent atrial tachyarrhythmia for which
catheter ablation and electrical cardioversion had been performed.
Transthoracic echocardiography demonstrated normal left ven-
tricular (LV) function, mild-to-moderate mitral regurgitation,
moderate aortic periprosthetic regurgitation, grade 3/4 LV diastolic
dysfunction consistent with severely increased LV filling pressure,
and a dilated ascending aorta. Computed tomography with 3-
dimensional reconstruction performed to evaluate the aorta (Figure
1) demonstrated an ascending aortic pseudoaneurysm, although the
entry site could not be identified. Coronary angiography and aor-
tography, respectively, revealed normal coronary arteries and a
pseudoaneurysm of the ascending aorta with what appeared to be
entry sites both proximally and distally.
Repair of the pseudoaneurysm was undertaken through a repeat
median sternotomy with femorofemoral cardiopulmonary bypass
and a transthoracic LV vent. Because of concern that the pseudo-
aneurysm would be entered, re-entry was undertaken only after
profound cooling to permit hypothermic circulatory arrest, if nec-
essary. Adhesions surrounding the aortic graft and forming the
wall of the pseudoaneurysm were extraordinarily dense.
Both proximal and distal suture lines were almost circumfer-
entially disrupted, and the aortic cuff appeared soft and friable.
Persistent concretions of BioGlue were identified between the
aortic layers. The previous graft was excised in its entirety, and the
cuff of the native aortic tissue was debrided of all visible traces of
BioGlue. Microscopy of resected aortic tissue revealed focal ad-
ventitial fibrosis, degenerating thrombus, amorphous biologic
glue, and focal acute and chronic nongranulomatous inflammation
(Figure 2).
An aortic valve periprosthetic leak was repaired, and the as-
cending aorta and hemiarch were rereplaced with a synthetic tube
graft. The patient made a satisfactory recovery and was discharged
on the 10th postoperative day.
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Figure 1. Computed tomographic scan with 3-dimensional re-
construction of the aorta demonstrating pseudoaneurysm
around the ascending aortic Dacron tube graft (posterior
view).
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 129, Number 4 937
Discussion
Biologic adhesive hemostatic sealants facilitate cardiac surgical
procedures and are particularly useful in cases in which the pro-
clivity for bleeding is high.1 Various biologic glues have been used
in cardiac surgery for more than 2 decades.2 Despite initial enthu-
siasm, late complications directly related to their use have become
apparent with time.3
Our experience raises concern about the potentially harmful
effects of BioGlue to local tissue. It has been our anecdotal
observation during reoperation on patients in whom large quanti-
ties of BioGlue appear to have been used that the substance
persists and that surrounding tissues are soft and friable. The
results of histologic study in the current case demonstrate an
ongoing local inflammatory process 2 years after application,
indicating that BioGlue might retard normal healing. This sub-
stance has previously been shown to impair tissue growth and
cause stricture formation in some circumstances4 and has been
shown to lead to tissue necrosis.5 These changes in structural
integrity might weaken the tissues and predispose to late compli-
cations, such as pseudoaneurysm formation, as has been previ-
ously suggested.6
Prior experience with other biologic glues3,5 might now evoke
a sense of déjà vu with BioGlue. There is no question that the
benefits of such agents in controlling blood loss in cardiac surgery
might be truly life-saving in some circumstances. Nevertheless,
their use should be parsimonious, and glues should not be consid-
ered substitutes for sutures and fastidious surgical hemostasis.
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Figure 2. Photomicrographs of aorta and biologic glue. A, Low-power view showing aortic wall and expansion of
adventitia by glue and tissue reaction. B and C, Biologic glue and adjacent platelet-fibrin thrombus. D, Focal
intense inflammatory response to glue, with infiltrates of lymphocytes and macrophages. (Hematoxylin and eosin;
Original magnification: A, 20; B, 100; C, 200; D, 400.)
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